轧机主传动直流电动机通风冷却系统的设计与应用

通过实例简述了扎机主传动直流电动机通风冷却系统的风机选择原则,方法及其风机房,风机基础和通风管略的设计与应用。     

粉末冶金真空炉专用新型热电偶与在线原位校准

从粉末冶金行业的精确生产与优质高效的战略出发,简述粉末冶金行业用钨铼热电偶的特点、分类与使用。详细论述粉末冶金真空炉专用超高真空(10~5 Pa)、超高压(15 MPa)密封式热电偶及炉温均匀性测试等新型传感器。详细探讨真空炉测温准确度的影响因素:真空度、发射率、热导率、热响应时间及热电偶的插入深度、热电偶保护管的选择等;简介进口真空炉专用热电偶国产化研究,国内外温度传感器性能对比及替代进口真空炉热电偶的成功业绩。目前,对测温系统的检定,多采用分立元件法,即对构成测温系统的元件及仪表分别进行检定。此种检定方法是离线的。本文简述离线式检定方法的诸多弊端以及美国宇航标准(AMS 2750E)中,有关系统准确度校准的特点及要求。详细论述在线原位校准的最新理念,最佳的系统准确度校准方案,并开发出与其配套、行之有效的带有校准孔的热电偶及便携式在线校准仪。为了提高测温系统的准确度,建议采用在线原位校准,方便易行,现已在国内推广应用。     

冶金企业实施安居工程建设中的设计技术管理

冶金企业实施国家安居工程在目前建设资金十分紧张的情况下靠自身的优势,走内涵挖潜的路子是十分有效的。在建设过程中充分发挥广大工程技术人员的作用,在设计和设计管理上给予强有力的保证非常重要。     

三杆式切断蝶阀的设计与开发

介绍了三杆式切断蝶阀的工作原理,并对世林(漯河)冶金设备有限公司研制开发的三杆式切断蝶阀结构形式、性能与特点做了详细分析。     

铁（Ⅲ）－1，10－二氮杂菲－甲基橙三元络合物光度法测定铁的研究

提出了铁（Ⅲ）－１,１０－二氮杂菲（Ｐｈｅｎ）－甲基橙（ＭＯ）三元络合物体系光度法测定Ｆｅ（Ⅲ）的新方法。该方法的灵敏度高（ε＝８．１×１０４）,选择性好,准确可靠,用于测定金属和化学试剂中痕量铁,结果满意。     

Effects of Technical Conditions on Structure, Morphology and Crystalline Size of Nanocrystalline Nd-Doped Ceria Powders

Nanocrystalline solid solution CeO2-Nd2O3 powders were prepared by low temperature combustion process.Special attention was paid to the influence of the glycine/metal ratio and calcination temperature on the powders phase structure, morphology and particle size.TG-DSC curves and XRD peaks of different glycine/metal ratio show that smaller particle size can be obtained with a slightly fuel-deficient ratio.XRD results indicate that the as-prepared powders are crystallized in a single fluorite structure.The crystalline size ranges from 9 to 24 nm, which increases with the increase of calcination temperature.The lower SEM images were characterized by the spongy and form-like microstructure of the powders.Organic agent may be gradually eliminated by high temperature calcination process.     

金矿矿源层和含金建造刍议

在矿源层评价中,相对于岩石中的金丰度,金的赋存状态具有更重要的意义,因此在工作中应恢复岩石的原始含金性,并计算区域金丰度值.本文还讨论了含金建造的概念、分布和评价准则等问题.     

p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis

Previous studies have indicated that milrinone, a specific type III phosphodiesterase inhibitor, may be able to induce chloride secretion in cystic fibrosis (CF) tissues. We have now assessed the effect of this agent in vivo on the nasal epithelium of CF mutant mice and also in the nose and lungs of human subjects with CF. Wild-type mice showed a small hyperpolarization of the nasal potential difference (PD) in response to milrinone (100 microM, 1.6 +/- 0.6 mV, n = 8, P < 0.05). In contrast, CF mice carrying either the most common human mutation of the gene for the CF transmembrane regulator (CFTR), DeltaF508 (protein mislocalized), or the G551D mutation (protein normally localized) failed to demonstrate this response. Milrinone perfused alone had no significant effect on the baseline nasal PD of human subjects without CF (14.7 +/- 4.0 mV preperfusion; 15.3 +/- 4.6 mV postperfusion), but significantly (P < 0.05) augmented the hyperpolarization induced by a subsequently perfused low-chloride solution (with milrinone, 36.8 +/- 3.0 mV, n = 6; without milrinone, 18.1 +/- 2.2 mV, n = 19). In contrast, in human subjects with CF (n = 6), milrinone alone significantly (P < 0. 05) altered the nasal baseline PD (52.2 +/- 3.3 mV preperfusion; 57. 4 +/- 4.2 mV, postperfusion) but not the subsequent responses to the low-chloride solution (with milrinone, 1.1 +/- 2.2 mV, n = 4; without milrinone, 0.6 +/- 0.5 mV, n = 28) or to isoproterenol (100 microM). In a separate study in subjects (n = 6) with the DeltaF508 mutation, nasal coadministration of milrinone with isoproterenol produced no effect in the presence of amiloride and a low-chloride solution (-0.8 +/- 0.5 mV). This was also the case in the nasal epithelium of CF subjects (n = 4) carrying at least one G551D allele (-0.3 +/- 0.8 mV). Similarly, milrinone did not hyperpolarize the PD of either the tracheal (n = 6) or segmental (n = 6) airways of CF subjects (DeltaF508) when applied topically in vivo in the presence of amiloride, isoproterenol, or adenosine triphosphate (all 100 microM) in a low-chloride solution. These data do not support the use of milrinone to induce chloride secretion in CF airways in vivo.